-
Review
February 28, 2024
- Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis
- Jiaorong Qu, Le Wang, Yufei Li, et al.
- Clin Mol Hepatol. 2024;30(3):303-325.
Articles in E-pub version are posted online ahead of regular printed publication.
- Original Article
- TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD
- Baokai Sun, Xiaoqian Ding, Jie Tan, Jie Zhang, Xueru Chu, Shuimi Zhang, Shousheng Liu, Zhenzhen Zhao, Shiying Xuan, Yongning Xin, Likun Zhuang
- Received April 16, 2024 Accepted July 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0268 [Accepted]
-
View: 21 Download: 2
- Gut microbiome and metabolome signatures in liver cirrhosis-related complications
- Satya Priya Sharma, Haripriya Gupta, Goo-Hyun Kwon, Sang Yoon Lee, Seol Hee Song, Jeoung Su Kim, Jeong Ha Park, Min Ju Kim, Dong-Hoon Yang, Hyunjoon Park, Sung-Min Won, Jin-Ju Jeong, Ki-Kwang Oh, Jung A Eom, Kyeong Jin Lee, Sang Jun Yoon, Young Lim Ham, Gwang Ho Baik, Dong Joon Kim, Ki Tae Suk
- Received May 10, 2024 Accepted July 24, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0349 [Accepted]
-
View: 45 Download: 3
- Diagnostic accuracy of the Fibrosis-4 index for advanced liver fibrosis in metabolic dysfunction-associated steatotic liver disease with type 2 diabetes: A systematic review and meta-analysis
- Ji Won Han, Hee Yeon Kim, Jung Hwan Yu, Mi Na Kim, Young Eun Chon, Ji Hyun An, Young-Joo Jin, Miyoung Choi, Seung Up Kim, Han Ah Lee, Dae Won Jun
- Received May 4, 2024 Accepted July 23, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0330 [Accepted]
-
View: 45 Download: 4
- DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease
- Amal Magdy, Hee-Jin Kim, Hanyong Go, Jun Min Lee, Hyun Ahm Sohn, Keeok Haam, Hyo-Jung Jung, Jong-Lyul Park, Taekyeong Yoo, Eun-Soo Kwon, Dong Hyeon Lee, Murim Choi, Keon Wook Kang, Won Kim, Mirang Kim
- Received April 9, 2024 Accepted July 24, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0229 [Accepted]
-
View: 42 Download: 6
- Erratum
- Erratum to ‘Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction’ [Clin Mol Hepatol 2024;30:539-560]
- Mehrangiz Dezhbord, Seong Ho Kim, Soree Park, Da Rae Lee, Nayeon Kim, Juhee Won, Ah Ram Lee, Dong-Sik Kim, Kyun-Hwan Kim
-
DOI: https://doi.org/10.3350/cmh.2024.0060e [Epub ahead of print]
-
View: 84 Download: 5
- Editorial
- UBE2S: A novel driver of HIF-1alpha-induced metabolic reprogramming in hepatocellular carcinoma
- Martina Mang Leng LEI, Terence Kin Wah LEE
- Received July 15, 2024 Accepted July 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0568 [Accepted]
-
View: 119 Download: 10
- Deep learning Assisted Biomarker Development in Patients with Chronic Hepatitis B
- Yong Eun Chung
- Received July 14, 2024 Accepted July 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0563 [Accepted]
-
View: 79 Download: 8
- Incretin based therapy in the management of metabolic dysfunction-associated steatotic liver disease (MASLD): one piece of the puzzle
- Tian-Yi Ren, Mohammed Eslam, Jian-Gao Fan
- Received July 14, 2024 Accepted July 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0558 [Accepted]
-
View: 90 Download: 8
- Correspondence
- Reply to: “Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind”
- Xiaoqian Xu, Hong You, Jidong Jia, Yuanyuan Kong
- Received July 12, 2024 Accepted July 21, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0552 [Accepted]
-
View: 93 Download: 5
- Original Article
- Transient elastography for significant fibrosis in treatment-naïve CHB patients: A systematic review and meta-analysis
- Mi Na Kim, Jihyun An, Eun Hwa Kim, Hee Yeon Kim, Han Ah Lee, Jung Hwan Yu, Young-Joo Jin, Young Eun Chon, Seung Up Kim, Dae Won Jun, Ji Won Han, Miyoung Choi
- Received May 18, 2024 Accepted July 23, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0371 [Accepted]
-
View: 132 Download: 13
- Genomic Biomarkers to Predict Response to Atezolizumab Plus Bevacizumab Immunotherapy in Hepatocellular Carcinoma: Insights from the IMbrave150 Trial
- Sun Young Yim, Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang-Hee Kang, Kena Park, Hyewon Park, Sunyoung S. Lee, Ahmed O. Kaseb, Young Nyun Park, Sun-Hee Leem, Michael A. Curran, Ji Hoon Kim, Ju-Seog Lee
- Received May 5, 2024 Accepted July 21, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0333 [Accepted]
-
View: 226 Download: 38
- Risk Assessment of Hepatitis B virus-related Hepatocellular Carcinoma Development Using Transient Elastography: Systematic Review and Meta-analysis
- Young-Joo Jin, Hee Yeon Kim, Miyoung Choi, Seung Up Kim, Young Ju Suh, Chae Hyeon Lee, Jung Hwan Yu, Mi Na Kim, Ji Won Han, Han Ah Lee, Jihyun An, Young Eun Chon, Dae Won Jun
- Received March 4, 2024 Accepted July 19, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0163 [Accepted]
-
View: 128 Download: 16
- Editorial
- Elimination of viral hepatitis: How far are we?
- Eun Ju Cho
- Received July 12, 2024 Accepted July 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0557 [Accepted]
-
View: 76 Download: 5
- Original Article
- Non-Linear Association Between Liver Fibrosis Scores and Viral Load in Patients with Chronic Hepatitis B
- Gi-Ae Kim, Seung Won Choi, Seungbong Han, Young-Suk Lim
- Received April 12, 2024 Accepted July 18, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0252 [Accepted]
-
View: 198 Download: 33
- Reply to Correspondence
- Reply to correspondence regarding “Class II Transactivator Restricts Viral Replication, Extending its Effect to HBV”
- Cho-Rong Lee, Sung-Gyoo Park
- Received July 16, 2024 Accepted July 17, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0572 [Accepted]
-
View: 131 Download: 13
- Editorial
- Reappraisal of Transarterial Radioembolization for Liver-Confined Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
- Jin Hyoung Kim, Gun Ha Kim, Dong Il Gwon
- Received July 3, 2024 Accepted July 16, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0516 [Accepted]
-
View: 112 Download: 16
- Reply to correspondence
- Response to: Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era
- Seren M. Gedallovich, Paul Y. Kwo
- Received July 10, 2024 Accepted July 11, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0546 [Accepted]
-
View: 131 Download: 3
- Review Article
- Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
- Mengyao Yan, Shuli Man, Long Ma, Lanping Guo, Luqi Huang, Wenyuan Gao
- Received April 28, 2024 Accepted July 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0315 [Accepted]
-
View: 315 Download: 38
- Original Article
- Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
- Chuan Liu, Hong You, Qing-Lei Zeng, Yu Jun Wong, Bingqiong Wang, Ivica Grgurevic, Chenghai Liu, Hyung Joon Yim, Wei Gou, Bingtian Dong, Shenghong Ju, Yanan Guo, Qian Yu, Masashi Hirooka, Hirayuki Enomoto, Amr Shaaban Hanafy, Zhujun Cao, Xiemin Dong, Jing LV, Tae Hyung Kim, Yohei Koizumi, Yoichi Hiasa, Takashi Nishimura, Hiroko Iijima, Chuanjun Xu, Erhei Dai, Xiaoling Lan, Changxiang Lai, Shirong Liu, Fang Wang, Ying Guo, Jiaojian Lv, Liting Zhang, Yuqing Wang, Qing Xie, Chuxiao Shao, Zhensheng Liu, Liu Ravaioli, Antonio Colecchia, Jie Li, Gao-Jun Teng, Xiaolong Qi
- Received March 22, 2024 Accepted July 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0198 [Accepted]
-
View: 374 Download: 55
- Correspondence
- Correspondence on Editorial regarding “Class II Transactivator Restricts Viral Replication and Extends Its Effect to HBV”
- Mehrangiz Dezhbord, Kyun-Hwan Kim
- Received July 3, 2024 Accepted July 8, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0515 [Accepted]
-
View: 177 Download: 34
- Editorial
- Nucleos(t)ide Analog Therapy of Chronic Hepatitis B and Extrahepatic Cancer Risk: Is tenofovir better than entecavir?
- Yewan Park, Dong Hyun Sinn
- Received July 4, 2024 Accepted July 7, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0519 [Accepted]
-
View: 174 Download: 28
- Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind
- Beom Kyung Kim
- Received June 30, 2024 Accepted July 7, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0499 [Accepted]
-
View: 148 Download: 4
- Correspondence
- The role of SPP1 in MASLD pathogenesis: Therapeutic insights into ursolic acid's mechanisms of action
- Yiyuan Zheng, Zhekun Xiong, Lina Zhao, Chaoyuan Huang, Qiuhong Yong, Dan Fang, Fengbin Liu, Yong Li
- Received June 24, 2024 Accepted July 5, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0471 [Accepted]
-
View: 150 Download: 14
- Correspondence on Editorial regarding“Macrophage ATG16L1: potential candidate for MASH treatment”
- Qi Wang, Qingfa Bu, Haoming Zhou, Ling Lu
- Received June 24, 2024 Accepted July 5, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0470 [Accepted]
-
View: 172 Download: 14
- Letter to the Editor
- Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
- Yixuan Zhu, Yee Hui Yeo, Xiaoyan Ma, Wenjing Ni, Junping Shi, Jie Li
- Received June 3, 2024 Accepted July 3, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0417 [Accepted]
-
View: 222 Download: 25
- Dipeptidyl peptidase-4 inhibitors are associated with improved survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy
- Dorothy Cheuk-Yan Yiu, Huapeng Lin, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Ken Liu, Terry Cheuk-Fung Yip
- Received April 18, 2024 Accepted July 4, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0280 [Accepted]
-
View: 178 Download: 19
- Editorial
- Class II Transactivator Restricts Viral Replication, Extending its Effect to HBV
- Cho-Rong Lee, Sung-Gyoo Park
- Received June 20, 2024 Accepted July 3, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0465 [Accepted]
-
View: 208 Download: 32
- Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis
- Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang
- Received June 25, 2024 Accepted June 29, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0482 [Accepted]
-
View: 277 Download: 16
- Correspondence
- Perspective of the risk and molecular mechanisms of hepatocellular carcinoma after HCV eradication in the post-DAA era
- Chung-Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, Ming-Lung Yu
- Received June 24, 2024 Accepted June 29, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0472 [Accepted]
-
View: 169 Download: 8
- Special Topic
- A new Korean nomenclature for steatotic liver disease: Nonalcoholic Fatty Liver Disease (NAFLD) Nomenclature Revision Consensus Task Force on behalf of the Korean Association for the Study of the Liver (KASL)
- Received June 26, 2024 Accepted June 30, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0467 [Epub ahead of print]
-
View: 205 Download: 36
- Review
- Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury
- Jia Liu, Ranyi Luo, Yinhao Zhang, Xiaojiaoyang Li
- Received April 3, 2024 Accepted June 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0222 [Accepted]
-
View: 293 Download: 57
- Editorial
- Engineering HBV-specific T cells for treatment of HBV-related HCC and HBV infection: past, present and future
- Antonio Bertoletti, Anthony T Tan
- Received June 23, 2024 Accepted June 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0469 [Accepted]
-
View: 205 Download: 26
- Review
- Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
- Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che-To Lai, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
- Received April 10, 2024 Accepted June 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0246 [Accepted]
-
View: 416 Download: 76
- Original Article
- UBE2S promotes glycolysis in hepatocellular carcinoma by enhancing E3 enzyme-independent polyubiquitination of VHL
- Renyu Zhang, Can Li, Shuai Zhang, Lingmin Kong, Zekun Liu, Yixiao Guo, Ying Sun, Cong Zhang, Yule Yong, Jianjun Lv, Meng Lu, Man Liu, Dong Wu, Tianjiao Zhang, Haijiao Yang, Ding Wei, Zhinan Chen, Huijie Bian
- Received April 7, 2024 Accepted June 24, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0236 [Accepted]
-
View: 390 Download: 86
- Burden of Mortality from Hepatocellular Carcinoma and Biliary Tract Cancers by Race and Ethnicity and Sex in US, 2018-2023
- Donghee Kim, Richie Manikat, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed
- Received April 29, 2024 Accepted June 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0318 [Accepted]
-
View: 346 Download: 25
- Correspondence
- Correspondence on Editorial regarding “Dynamic Assessment of Modified Quick Sequential Organ Failure Assessment in Acutely Deteriorated Patients with Chronic Liver Disease”
- Do Seon Song, Dong Joon Kim
- Received June 12, 2024 Accepted June 14, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0448 [Accepted]
-
View: 438 Download: 5
- Editorial
- Macrophage ATG16L1: potential candidate for MASH treatment
- Junjie Yu
- Received June 11, 2024 Accepted June 14, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0443 [Accepted]
-
View: 348 Download: 25
- Letter to the Editor
- MAFLD-related hepatocellular carcinoma in China: An increasing problem
- Xiangyu Wu, Wenjing Ni, Qianqian Chen, Junping Shi, Jie Li
- Received May 22, 2024 Accepted June 17, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0386 [Accepted]
-
View: 421 Download: 29
- Editorial
- The impact of ischemia-free liver transplantation to improve the prognosis of recipients using functionally marginal liver grafts
- Ho Joong Choi
- Received June 4, 2024 Accepted June 6, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0426 [Accepted]
-
View: 299 Download: 16
- Metformin and Statins and their role in reducing Hepatocellular Carcinoma Risk: Randomized trials are needed
- Paul Y. Kwo
- Received June 4, 2024 Accepted June 6, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0425 [Accepted]
-
View: 446 Download: 22
- Meeting the challenges of HCC post SVR in the Post-DAA Era: A Path Forward
- Seren M. Gedallovich, Paul Y. Kwo
- Received June 3, 2024 Accepted June 6, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0418 [Accepted]
-
View: 383 Download: 12
- Ursolic acid: A promising therapeutic agent for MASLD via inhibition of SPP1-induced Th17 cell differentiation
- So Jung Kim, Jeongeun Hyun
- Received May 31, 2024 Accepted June 6, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0412 [Accepted]
-
View: 605 Download: 32
- Modified quick-SOFA score: can it enhance prognostic assessment for hospitalized patients with chronic liver diseases?
- Simone Incicco, Salvatore Piano
- Received May 30, 2024 Accepted May 31, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0409 [Accepted]
-
View: 353 Download: 7
- Correspondence
- Correspondence on editorial regarding “Atezolizumab and bevacizumab for hepatocellular carcinoma: how to approach salvage therapy for non-responders?”
- Young Eun Chon, Dong Yun Kim, Hong Jae Chon, Do Young Kim
- Received May 24, 2024 Accepted May 29, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0394 [Accepted]
-
View: 402 Download: 25
- Original Article
- Genetically redirected HBV-specific T cells target HBsAg-positive hepatocytes and primary lesions in HBV-associated HCC
- Xueshuai Wan, Karin Wisskirchen, Tao Jin, Lu Yang, Xiaorui Wang, Xiang’an Wu, Fang Liu, Yu Wu, Christy Ma, Yong Pang, Qi Li, Ke Zhang, Ulrike Protzer, Shunda Du
- Received January 20, 2024 Accepted May 28, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0058 [Accepted]
-
View: 553 Download: 92
- Editorial
- MAFLD Is A Ubiquitous Latent Cofactor in Viral- and Alcoholic-related Hepatocellular Carcinoma
- Toru Nakamura, Masahito Nakano, Tsubasa Tsutsumi, Keisuke Amano, Takumi Kawaguchi
- Received May 18, 2024 Accepted May 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0372 [Accepted]
-
View: 449 Download: 30
- Correspondence
- Correspondence on Editorial regarding “Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: a gateway to personalized medicine”
- Su Bin Lim, Hyo Jung Cho
- Received May 16, 2024 Accepted May 19, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0368 [Accepted]
-
View: 373 Download: 21
- Reply to Unlocking the future: machine learning sheds light on prognostication for early-stage hepatocellular carcinoma
- Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
- Received May 16, 2024 Accepted May 19, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0365 [Accepted]
-
View: 347 Download: 11
- Reply to Correspondence
- Reply to correspondence: “Prognosis of biopsy-confirmed MASLD: A sub-analysis of the CLIONE study”
- Eileen Laurel Yoon, Dae Won Jun
- Received May 15, 2024 Accepted May 19, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0360 [Accepted]
-
View: 359 Download: 10
- Letter to the Editor
- Equivalent Prevalence and Progression of Chronic Kidney Disease in NAFLD and MASLD
- Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi
- Received April 15, 2024 Accepted May 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0264 [Accepted]
-
View: 457 Download: 53
- Correspondence
- Correspondence on Editorial regarding “Liver Sinusoidal Endothelial Cell: An Important Yet Often Overlooked Player in the Liver Fibrosis”
- Jiaorong Qu, Le Wang, Xiaojiaoyang Li
- Received May 14, 2024 Accepted May 15, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0357 [Accepted]
-
View: 363 Download: 26
- Editorial
- Unveiling Etiology-Specific Blood Biomarkers in Hepatocellular Carcinoma: A Gateway to Personalized Medicine
- Joseph C. Ahn, Ju Dong Yang
- Received May 10, 2024 Accepted May 13, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0348 [Accepted]
-
View: 385 Download: 8
- Core protein inhibitors: Opportunities and challenges at the forefront of hepatitis B cure
- Hae Lim Lee, Jeong Won Jang
- Received May 9, 2024 Accepted May 13, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0346 [Accepted]
-
View: 261 Download: 21
- Unlocking the Role of Liver Sinusoidal Endothelial Cells: Key Players in Liver Fibrosis
- Yasuko Iwakiri
- Received May 8, 2024 Accepted May 9, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0343 [Accepted]
-
View: 392 Download: 45
- Letter to the Editor
- Changing from NAFLD to MASLD: Cumulative incidence of gallstones between patients with NAFLD and those with MASLD in Asia
- Shuhei Fukunaga, Tomoyuki Nakane, Michita Mukasa, Hidetoshi Takedatsu, Takumi Kawaguchi
- Received April 7, 2024 Accepted May 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0233 [Accepted]
-
View: 399 Download: 32 Crossref: 1
- Editorial
- Unlocking the future: Machine learning sheds light on prognostication for early-stage hepatocellular carcinoma
- Junlong Dai, Jimmy Che-To Lai, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
- Received May 3, 2024 Accepted May 4, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0327 [Epub ahead of print]
-
View: 365 Download: 20
- Atezolizumab and bevacizumab for hepatocellular carcinoma: how to approach salvage therapy for non-responders?
- Naoshi Nishida
- Received May 2, 2024 Accepted May 3, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0324 [Accepted]
-
View: 350 Download: 44
- Reply to Correspondence
- Complement proteins and liver diseases: A response to the correspondence
- Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang
- Received April 30, 2024 Accepted April 30, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0320 [Epub ahead of print]
-
View: 489 Download: 36
- Correspondence
- Reply to: “Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization”
- Yingzhou Shi, Guandou Yuan, Xiude Fan, Chao Xu
- Received April 16, 2024 Accepted April 19, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0266 [Epub ahead of print]
-
View: 438 Download: 16
- Reply to correspondence
- Reply to correspondence regarding “Evaluation of the histological scoring systems for autoimmune hepatitis: A significant step towards the optimization of clinical diagnosis”
- Atsumasa Komori
- Received April 9, 2024 Accepted April 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0242 [Epub ahead of print]
-
View: 616 Download: 18
- Reply to Correspondence
- Reply to “Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B”
- Pin-Nan Cheng, Ming-Lung Yu
- Received April 5, 2024 Accepted April 9, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0228 [Epub ahead of print]
-
View: 560 Download: 24
- Snapshot
- Examining the therapeutic landscape of beta-blockers in portal hypertension
- Anna Brujats, Càndid Villanueva
- Received February 24, 2024 Accepted March 4, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0144 [Epub ahead of print]
-
View: 1580 Download: 33
